Sponsored Links
| Development Of ADX10059 Ended For Long-Term Use |
 |
 |
 |
| Medical News - Acid Reflux and GERD | |||
|
Addex Pharmaceuticals (SWISS: ADXN) announced that based on preliminary review of the unblinded data from study 206, it has terminated development of ADX10059 for chronic indications, including long term treatment of gastroesophageal reflux disease and migraine prophylaxis... Read more: Acid Reflux / GERD News From Medical News Today
|